Different Approaches for the Management of Post-dural Puncture Headache
Status:
Completed
Trial end date:
2020-12-30
Target enrollment:
Participant gender:
Summary
Detecting the efficacy and safety of trans-nasal sphenopalatine ganglion block using either
lidocaine 2% or bupivacaine 0.5 % as a treatment line for post-dural puncture headache